Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Musculoskeletal Disorders: Prevention and Treatment, RFA OH-02-004

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Musculoskeletal Disorders: Prevention and Treatment, RFA OH-02-004.

Times and Dates: 8 a.m.-8:30 a.m., March 12, 2002 (Open), 8:40 a.m.-5 p.m., March 12, 2002 (Closed), 8 a.m.-5 p.m., March 13, 2002 (Closed).

Place: Harbor Court Hotel, 550 Light Street, Baltimore MD 21202.

Status: Portions of the meeting will be closed to the public in accordance with Start Printed Page 8810provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to RFA OH-02-004.

Start Further Info

CONTACT PERSON FOR MORE INFORMATION:

Pervis Major, Ph.D., Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, M/S B228, telephone (304) 285-5979.

The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: February 20, 2002.

Alvin Hall,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

End Signature End Further Info End Preamble

[FR Doc. 02-4508 Filed 2-25-02; 8:45 am]

BILLING CODE 4163-19-P